Related Experiment Video

Updated: Jan 3, 2026

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.2K

TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its

Reza Bahramabadi1, Shahriar Dabiri1, Maryam Iranpour1

  • 1Pathology and Stem Cell Research Center, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Viral Immunology
|November 14, 2019
PubMed

Insights

Toll-like receptor 4 (TLR4) may play a crucial role in human papillomavirus (HPV) infections and associated cancers. This review explores TLR4's potential involvement in the HPV-cancer puzzle and immune response.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Human papillomavirus (HPV) is a primary cause of cervical cancer.
  • Immune responses are critical for clearing HPV infections and influence cancer development.
  • Toll-like receptors (TLRs) are key innate immunity receptors involved in fighting infections and cancer progression.

Purpose of the Study:

  • To investigate the potential role of Toll-like receptor 4 (TLR4) in human papillomavirus (HPV) infection and related complications.
  • To explore the hypothesis that TLR4 is a significant factor in the HPV-cancer pathway.

Main Methods:

  • This review article systematically collected and analyzed existing scientific literature.
  • Information regarding the plausible roles of TLR4 in HPV infection and cervical cancer was gathered.

Main Results:

  • Toll-like receptors (TLRs) are integral to innate immunity, mediating responses to infectious agents and influencing cancer.
  • TLR4, a unique TLR, utilizes known intracellular signaling pathways and has demonstrated roles in combating viral infections and associated tumors.
  • The review consolidates evidence suggesting TLR4's potential significance in the context of HPV infection and cervical cancer development.

Conclusions:

  • TLR4 is hypothesized to play a key role in the complex interplay between HPV infection and the development of associated cancers.
  • Further research into TLR4's function could elucidate novel therapeutic strategies for HPV-related malignancies.
Keywords:
TLR4cancerhuman papillomavirus

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.8K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.7K

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
907